Taiwan’s first-dose coverage for COVID-19 vaccination has already reached 70 percent, but rollout of subsequent doses has only reached 30 percent coverage and enthusiasm is waning.
To address this, the Central Epidemic Command Center is pushing for people to get their second AstraZeneca shot and reduce the time between shots of the Pfizer-BioNTech vaccine to four weeks, the smallest gap advised.
This is misguided, because the coverage rate does not necessarily equate with optimal protection.
Large-scale trials conducted in Sweden recently showed that a mix of the AstraZeneca and Moderna shots offers 79 percent protection against the Delta variant of SARS-CoV-2 compared with protection of 30 percent from two AstraZeneca shots, while an AstraZeneca-Pfizer-BioNTech combination provided 67 percent protection.
More than 7 million Taiwanese, about one-third of the population, have had a first jab of the AstraZeneca vaccine. If the study’s data hold true, a second AstraZeneca shot would boost the coverage by more than 30 percent, but the protection rate would only be half of that.
However, if those 7 million were to be given Moderna for dose No. 2, the protection rate would be much greater.
By the same principle, if Taiwan is seeking to fully vaccinate 60 percent of the population, but more than 7 million people are given two AstraZeneca jabs, the protection rate would be at best 45 percent.
In the absence of community prevention measures, the Delta variant has a basic reproduction number (R) — the expected number of cases directly generated by one case in a population in which everyone is susceptible to infection — of 6. If the government is relying solely on herd immunity, it needs to achieve 83 percent immunity. Such a figure is only possible in a population completely inoculated with an mRNA vaccination, with the exception of children, who still cannot be vaccinated.
However, if the AstraZeneca vaccine was used exclusively, even with a 100 percent vaccination rate, the nation would be nowhere near herd immunity.
Many people mistakenly believe that as the AstraZeneca and mRNA vaccines prevent serious symptoms from developing in 90 percent of cases, they are virtually the same.
However, the point of the next phase of pandemic prevention measures is to reduce the incidence of less severe symptoms.
Singapore, which has deployed exclusively mRNA vaccines, has reduced incidents of severe infections, but as it opens its borders to visitors from some countries and eases other restrictions, those who are yet to be vaccinated, especially elderly people, face trouble.
If there are breakthrough infections, the death rate among elderly people might be as high as 2 percent, far above the rate of influenza deaths.
Regarding the wait period, why was the previous advice that there should be a 10-week wait between Moderna jabs, but now a second BioNTech jab can be received after four weeks?
The recommended wait period for the BioNTech vaccine is three weeks, but studies in Europe showed that protection levels improved with a 10-week wait, so many people delayed their second shot.
A US study in July showed that protection from two BioNTech shots fell to only 40 percent after five months, with one of the reasons possibly that the time between jabs was too short.
If Taiwan wants to open its borders, it must ensure that it has the best possible protection from its vaccination program. This means allowing those who have gotten an AstraZeneca jab to receive a different brand for their second shot, while those who have had the first shot of an mRNA vaccine to should wait 10 weeks before getting their second.
Taiwanese should not be fooled into thinking that they are adequately protected simply because they have had two shots.
Shen Chen-nan is a physician.
Translated by Paul Cooper
On May 7, 1971, Henry Kissinger planned his first, ultra-secret mission to China and pondered whether it would be better to meet his Chinese interlocutors “in Pakistan where the Pakistanis would tape the meeting — or in China where the Chinese would do the taping.” After a flicker of thought, he decided to have the Chinese do all the tape recording, translating and transcribing. Fortuitously, historians have several thousand pages of verbatim texts of Dr. Kissinger’s negotiations with his Chinese counterparts. Paradoxically, behind the scenes, Chinese stenographers prepared verbatim English language typescripts faster than they could translate and type them
More than 30 years ago when I immigrated to the US, applied for citizenship and took the 100-question civics test, the one part of the naturalization process that left the deepest impression on me was one question on the N-400 form, which asked: “Have you ever been a member of, involved in or in any way associated with any communist or totalitarian party anywhere in the world?” Answering “yes” could lead to the rejection of your application. Some people might try their luck and lie, but if exposed, the consequences could be much worse — a person could be fined,
Taiwan aims to elevate its strategic position in supply chains by becoming an artificial intelligence (AI) hub for Nvidia Corp, providing everything from advanced chips and components to servers, in an attempt to edge out its closest rival in the region, South Korea. Taiwan’s importance in the AI ecosystem was clearly reflected in three major announcements Nvidia made during this year’s Computex trade show in Taipei. First, the US company’s number of partners in Taiwan would surge to 122 this year, from 34 last year, according to a slide shown during CEO Jensen Huang’s (黃仁勳) keynote speech on Monday last week.
On May 13, the Legislative Yuan passed an amendment to Article 6 of the Nuclear Reactor Facilities Regulation Act (核子反應器設施管制法) that would extend the life of nuclear reactors from 40 to 60 years, thereby providing a legal basis for the extension or reactivation of nuclear power plants. On May 20, Chinese Nationalist Party (KMT) and Taiwan People’s Party (TPP) legislators used their numerical advantage to pass the TPP caucus’ proposal for a public referendum that would determine whether the Ma-anshan Nuclear Power Plant should resume operations, provided it is deemed safe by the authorities. The Central Election Commission (CEC) has